Stem cells as potential therapeutic targets for inflammatory bowel disease

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 3, 2010, Pages 993-1008

  Singh, Udai P ^a   Singh, Narendra P ^a   Singh, Balwan ^b   Mishra, Manoj K ^c   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a   Singh, Shree Ram ^d  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c ALABAMA STATE UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; Review; Stem cells; Ulcerative colitis

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CROHN DISEASE; DISEASE MODEL; ENTERITIS; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; ULCERATIVE COLITIS;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77956620890     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s115     Document Type: Review

References (145)

1. Podolsky, D.K.: Inflammatory bowel disease. N Engl J Med, 325, 928-937 (1991)
2. Sands, B. E.: Inflammatory bowel disease: past, present, and future. J Gastroenterol, 42, 16-25 (2007) (Pubitemid 46351421)
3. Xavier, R. J. & D. K. Podolsky: Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448, 427-34. 2007 (Pubitemid 47123518)
4. Kappelman, M. D., S. L. Rifas-Shiman, K. Kleinman, D. Ollendorf, A. Bousvaros, R. J. Grand, & J. A. Finkelstein: The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol, 5, 1424-9 (2007) (Pubitemid 350181588)
5. Herrinton, L. J., L. Liu, J.E., Lafata, J. E. Allison, S. E. Andrade, E. J. Korner, K. A. Chan, R. Platt, D. Hiatt, & S. O'Connor: Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis, 13, 451-61 (2007) (Pubitemid 46668251)
6. Loftus, E.V. Jr.: The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol, 5, 1383-4 (2007) (Pubitemid 350181612)
7. Hay, A.R., & J.W. Hay: Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol, 14:318-327 (1992)
8. Kappelman, M. D., S. L. Rifas-Shiman, C. Q. Porter, D. Ollendorf, R. S. Sandler, J. A. Galanko, & J. A. Finkelstein: Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology, 135, 1907-13 (2008)
9. Ananthakrishnan, A. N., E. L., McGinley & D. G. Binion: Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis, 15, 182-9 (2009)
10. Mizoguchi, A. & E. Mizoguchi: Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol, 43, 1-17 (2008) (Pubitemid 351324980)
11. Kaplan, G.G., R. Panaccione, J. N. Hubbard, G. C. Nguyen, A. A. Shaheen, C. Ma, S. M. Devlin, Y. Leung & R. p. Myers: Inflammatory bowel disease patients who leave hospital against medical advice: predictors and temporal trends. Inflamm Bowel Dis, 15, 845-51 (2009)
12. Halfvarson, J., L. Bodin, C. Tysk, E. Lindberg, & G. Järnerot: Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology, 124, 1767-73 (2003) (Pubitemid 36666773)
13. Lees, C.W. & J. Satsangi: Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol, 3, 513-34 (2009)
14. Franke, A., T. Balschun, T. H. Karlsen, J. Sventoraityte, S. Nikolaus, G. Mayr, F.S. Domingues, M. Albrecht, M. Nothnagel, D. Ellinghaus, C. Sina, C. M. Onnie, R. K. Weersma, P. C. Stokkers, C. Wijmenga, M. Gazouli, D. Strachan, W. L. McArdle, S. Vermeire, P. Rutgeerts, P. Rosenstiel, M. Krawczak, M. H. Vatn; IBSEN study group, C. G. Mathew & S. Schreiber: Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet, 40, 1319-23 (2008)
15. Rodriguez-Bores, L., G. C. Fonseca, M. A. Villeda, J. K. Yamamoto-Furusho: Novel genetic markers in inflammatory bowel disease. World J Gastroenterol, 13, 5560-70 (2007) (Pubitemid 350031475)
16. Cho, J. H. & C. Abraham: Inflammatory bowel disease genetics: Nod2. Annu Rev Med, 58, 401-16 (2007) (Pubitemid 46706523)
17. Barrett, J. C., S. Hansoul, D. L. Nicolae, J. H. Cho, R. H. Duerr, J. D. Rioux, S. R. Brant, M. S. Silverberg, K. D. Taylor, M. M., A. Barmada Bitton, T. Dassopoulos, L. W. Datta, T. Green, A M. Griffiths, E. O. Kistner, M. T. Murtha, M. D Regueiro, J. I. Rotter, L. p. Schumm, A. H. Steinhart, S. R. Targan, R. J. Xavier, NIDDK IBD Genetics Consortium, C. Libioulle, C. Sandor, M. Lathrop, J. Belaiche, O. Dewit, I. Gut, S. Heath, D. Laukens, M. Mni, P. Rutgeerts, A. Van Gossum, D. Zelenika, D. Franchimont, J. p. Hugot, M. de Vos, S. Vermeire, E. Louis, Belgian-French IBD Consortium, Wellcome Trust Case Control Consortium, L. R. Cardon, C. A. Anderson, H Drummond, E. Nimmo, T. Ahmad, N. J. Prescott, C. M. Onnie, S. A. Fisher, J. Marchini, J. Ghori, S. Bumpstead, R. Gwilliam, M. Tremelling, P. Deloukas, J. Mansfield, D. Jewell, J. Satsangi, C. G. Mathew, M. Parkes, M. Georges & M. J. Daly. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet, 40, 955-62 (2008)
18. Zhang, H. D. Massey, M. Tremelling, & M. Parkes: Genetics of inflammatory bowel disease: clues to pathogenesis. Br Med Bull, 87, 17-30 (2008)
19. Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, J. p. Achkar, S. R. Brant, T. M. Bayless, B. S. Kirschner, S. B. Hanauer, G. Nuez, & J. H. Cho: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606 (2001) (Pubitemid 32531409)
20. Stoll, M., B. Corneliussen, C.M. Costello, G.H. Waetzig, B. Mellgard, W.A. Koch, P. Rosenstiel, M. Albrecht, P.J. Croucher, D. Seegert, S. Nikolaus, J. Hampe, T. Lengauer, S. Pierrou, U.R. Foelsch, C.G. Mathew, M. Lagerstrom-Fermer & S. Schreiber: Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet, 36, 476-480 (2004) (Pubitemid 38620031)
21. Peltekova, V.D., R.F. Wintle, L.A. Rubin, C.I. Amos, Q. Huang, X. Gu, B. Newman, M. Van Oene, D. Cescon, G. Greenberg, A.M. Griffiths, P.H. St George-Hyslop & K. A. Siminovitch: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet, 36, 471-475 (2004) (Pubitemid 38620030)
22. Neurath, M.F., S. Finotto & L.H. Glimcher: The role of Th1/Th2 polarization in mucosal immunity. Nat Med, 8, 567-573 (2002) (Pubitemid 34633433)
23. Elphick, D.A. & Y.R. Mahida: Paneth cells: their role in innate immunity and inflammatory disease. Gut, 54: 1802-1809 (2005) (Pubitemid 41697682)
24. Abreu, M.T. & M.P. Sparrow: Translational research in inflammatory bowel disease. Mt Sinai J Med, 73, 1067-73 (2006) (Pubitemid 46370336)
25. Van Limbergen, J., R.K. Russell, E.R. Nimmo & J. Satsangi: The genetics of inflammatory bowel disease. Am J Gastroenterol, 102, 2820-2831 (2007) (Pubitemid 350179337)
26. Brant, S.R., & Y.Y. Shugart: Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Inflamm Bowel Dis, 10, 300-311 (2004) (Pubitemid 38618262)
27. Fuss, I.J., F. Heller, M. Boirivant, F. Leon, M. Yoshida, S. Fichtner-Feigl, Z. Yang, M. Exley, A. Kitani, R.S. Blumberg, P. Mannon & W. Strober: Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest, 113, 1490-1497 (2004) (Pubitemid 39071705)
28. Singh, U.P., S. Singh, R. Singh, Y. Cong, D.D. Taub & J.W. Lillard Jr: Chronic colitis and CXCL10-producing mucosal T helper, NK and NKT cells in IL10-/-mice can be abrogated by CXCL10 blockade. J Interf Cytok Res, 28, 31-43. (2008)
29. Singh, U.P., S. Singh, C. Venkataraman & J.W. Lillard Jr: CXCR3 Axis: Role in Inflammatory Bowel Disease and its Therapeutic Implication. Endocr Metabol Immu Disord: Drug Target, 7, 111-123 (2007) (Pubitemid 46969859)
30. Singh, U.P., S. Singh, R. Singh, F. D. Quinn, M. E. Potter & J. W. Lillard Jr: Influence of Mycobacterium avium paratuberculosis on colitis development and specifics immune responses during disease. Infec Immun, 75, 3722-3278 (2007)
31. Yu, Q.T., M. Saruta, A. Avanesyan, P.R. Fleshner, A.H. Banham & K.A. Papadakis: Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis, 13: 191-199 (2007) (Pubitemid 46806228)
32. Koloski, N.A., Bret L, G. Radford-Smith: Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol, 14, 165-73 (2008) (Pubitemid 351314294)
33. Lanzoni, G., G. Roda, A. Belluzzi, E. Roda & G.P. Bagnara: Inflammatory bowel disease: Moving toward a stem cell-based therapy. World J Gastroenterol, 14, 4616-26 (2008)
34. Gionchetti, P., F. Rizzello, K.M. Lammers, C. Morselli, L. Sollazzi, S. Davies, R. Tambasco, C. Calabrese & M. Campieri: Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol, 12, 3306-13 (2006) (Pubitemid 43933773)
35. Boden, E.K. & S.B. Snapper: Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol, 24, 733-41 (2008)
36. Sartor, R.B. & M. Muehlbauer: Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep, 9, 497-507 (2007) (Pubitemid 351795708)
37. Bank, U., U.R. Bohr, D. Reinhold, U. Lendeckel, S. Ansorge, P. Malfertheiner & M. Tager: Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors. Front Biosci, 13, 3699-713 (2008) (Pubitemid 351594653)
38. Zhong, W., J.K. Kolls, H. Chen, F. McAllister, P.D. Oliver & Z. Zhang: Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease. Front Biosci, 13, 1654-64 (2008) (Pubitemid 351599723)
39. Abraham, C. & J. Cho: Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis, 15, 1090-100 (2009)
40. Rosenstiel, P., C. Sina, A. Franke & S. Schreiber: Towards a molecular risk map - recent advances on the etiology of inflammatory bowel disease. Semin Immunol, 21, 334-45 (2009)
41. Singh, S.R. & S.X. Hou: Multipotent stem cells in the Malpighian tubules of adult Drosophila melanogaster. J Exp Biol, 212, 413-23 (2009)
42. Arthur, A., A. Zannettino & S. Gronthos: The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol, 218, 237-45 (2009)
43. Kuhn, N.Z. & R.S. Tuan: Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol, 222, 268-77 (2010)
44. Mishra, p. K., S. R. Singh, I. G. Joshua, & S. C. Tyagi: Stem cells as a therapeutic target for diabetes Front Biosc, 15, 461-477 (2010)
45. Schwartz, D.A. & B.E. Maltz: Treatment of fistulizing inflammatory bowel disease. Med Clin North Am, 94, 19-34 (2010)
46. MacDonald, T.T. & S. Pettersson: Bacterial regulation of intestinal immune responses. Infl. Bowel Dis, 6, 116-122 (2000)
47. Powrie, F. & M.W. Leach: Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther Immunol, 2, 115-123 (1995) (Pubitemid 26101860)
48. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky & W. Muller: Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263-274 (1993) (Pubitemid 23320290)
49. Elson, C.O., R.B. Sartor, G.S. Tennyson & R.H. Riddell: Experimental models of inflammatory bowel disease. Gastroenterology, 109, 1344-1367 (1995)
50. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller & I. Horak: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 75, 253-261 (1993) (Pubitemid 23320289)
51. Lashner, B.: Inflammatory bowel disease. In: Gastroenterology, Current Clinical Medicine. Elsevier (2009)
52. Bai, A., N. Lu, Y. Guo, Z. Liu, J. Chen & Z. Peng: Alltrans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol, 86, 959-69 (2009)
53. Fiocchi, C.: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology, 115, 182-205 (1998) (Pubitemid 28307304)
54. Fuss, I.J., R.O. Ehrhardt, M. Neurath, M. Boirivant, B. R. Ludviksson & W. Strober: The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Scand J Immunol, 48, 453-458 (1998) (Pubitemid 28505667)
55. Monteleone, G.: Esponse of human intestinal lamina propria T lymphocytes to interleukin additive effects of interleukin 15 and 7. Gut, 43, 735-736 (1998)
56. Sundaramoorthi, R., C. Siedem, C.B. Vu, D.C. Dalgarno, E.C. Laird, M.C. Botfield, A.B. Combs, S.E. Adams, R.W. Yuan, M. Weigele & S.S. Narula: Selective inhibition of Src SH2 by a novel thiol-targeting tricarbonyl-modified inhibitor and mechanistic analysis by (1)H/(13)C NMR spectroscopy. Bioorg MedChem Lett, 11, 1665-1669 (2001) (Pubitemid 32568293)
57. Cong, Y., A. Konrad, N. Iqbal & C.O. Elson: Probiotics and immune regulation of inflammatory bowel diseases. Curr Drug Targets Inflamm Allergy, 2, 145-54 (2003)
58. Heller, F., P. Florian, C. Bojarski, J. Richter, M. Christ, B. Hillenbrand, J. Mankertz, A.H. Gitter, N. Bürgel, M. Fromm, M. Zeitz, I. Fuss, W. Strober & J.D. Schulzke: Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology, 129, 550-64 (2005) (Pubitemid 41096643)
59. Monteleone, G., I. Monteleone, D. Fina, P. Vavassori, G. Del Vecchio Blanco, R. Caruso, R. Tersigni, L. Alessandroni, L. Biancone, G.C. Naccari, T.T. MacDonald & F. Pallone: Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology, 128, 687-94 (2005) (Pubitemid 40585371)
60. Duerr, R.H., K.D. Taylor, S.R. Brant, J.D. Rioux, M.S. Silverberg, M.J. Daly, A.H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, T. Dassopoulos, A. Bitton, H. Yang, S. Targan, L.W. Datta, E.O. Kistner, L.P. Schumm, A.T. Lee, P.K. Gregersen, M.M. Barmada, J.I. Rotter, D.L. Nicolae & J. H. Cho: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science, 314, 1461-3 (2006) (Pubitemid 44871953)
61. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, & K. H. Meyer zum Buschenfelde: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol, 102, 448-455 (1995) (Pubitemid 26013210)
62. Nakajima, A., T. Kodama, Y. Yazaki, M. Takazoe, N. Saito, R. Suzuki, H. Nishino, K. Yamamoto, J. Silver, & N. Matsuhashi: Specific clonal T cell accumulation in intestinal lesions of Crohn's disease. J Immunol, 157, 5683-5688 (1996) (Pubitemid 126448993)
63. Probert, C.S., A. Chott, J.R. Turner, L.J. Saubermann, A.C. Stevens, K. Bodinaku, C.O. Elson, S.P. Balk & R.S. Blumberg: Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. J Immunol, 157, 3183-3191(1996) (Pubitemid 126450082)
64. Maynard, C.L. & C.T. Weaver: Intestinal effector T cells in health and disease. Immunity, 31, 389-400 (2009)
65. Kobayashi, M., H. Hoshino, J. Masumoto, M. Fukushima, K. Suzawa, S. Kageyama, M. Suzuki, H. Ohtani, M. Fukuda & N. Nakayama: GlcNAc6ST-1-mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitis. Inflamm Bowel Dis, 15, 697-706 (2009)
66. McGeachy, M.J., Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, W.M. Blumenschein, T.K. McClanahan, J.J. O'Shea & D. J. Cua: The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol, 10, 314-24 (2009)
67. Orholm, M., P. Munkholm, E. Langholz, O. H. Nielsen, T. I. Sorensen & V. Binder: Familial occurrence of inflammatory bowel disease. N Engl J Med, 324, 84-88 (1991)
68. Hanauer, S.B.: New steroids for IBD: progress report. Gut, 51, 182-3 (2002) (Pubitemid 34791443)
69. Hawthorne, A.B. & G. Rubin & S. Ghosh: Review article: medication non-adherence in ulcerative colitis - strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther, 27, 1157-66 (2008) (Pubitemid 351697281)
70. Toruner, M., E.V. Loftus Jr, W.S. Harmsen, A.R. Zinsmeister, R. Orenstein, W.J. Sandborn, J.F. Colombel & L.J. Egan: Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology, 134, 929-36 (2008) (Pubitemid 351451967)
71. Sandborn, W.J., B. G. Feagan & G. R. Lichtenstein: Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission. Aliment Pharmacol Ther, 26, 987-1003 (2007) (Pubitemid 47416299)
72. Lichtenstein, G.R., R.H. Diamond, C.L. Wagner, A.A. Fasanmade, A.D. Olson, C.W. Marano, J. Johanns, Y. Lang & W. J. Sandborn: Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials. Aliment Pharmacol Ther, 30, 210-26 (2009)
73. Nguyen, G.C., M.L. Harris & T. Dassopoulos: Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease. Curr Gastroenterol Rep, 8, 499-505 (2006) (Pubitemid 46017162)
74. Feagan, B.G.: Maintenance therapy for inflammatory bowel disease. Am J Gastroenterol, 98, S6-S17 (2003) (Pubitemid 38044602)
75. Thia, K.T., E.V. Loftus Jr, W.J. Sandborn & S. K. Yang: An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol, 103, 3167-82 (2008)
76. van Dullemen, H.M., S.J. van Deventer, D.W. Hommes, H.A. Bijl, J. Jansen, G.N. Tytgat & J. Woody: Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology, 109: 129-135 (1995)
77. ten Hove, T., C. van Montfrans, M.P. Peppelenbosch & S. J. van Deventer: Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut, 50, 206-211 (2002) (Pubitemid 34087933)
78. Breese, E.J., C.A. Michie, S.W. Nicholls, S.H. Murch, C.B. Williams, P. Domizio, J.A., Walker-Smith & T. T. MacDonald: Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology, 106, 1455-1466 (1994) (Pubitemid 24163114)
79. Reimund, J.M., C. Wittersheim, S. Dumont, C.D. Muller, J.S. Kenney, R. Baumann, P. Poindron & B. Duclos: Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut, 39, 684-689 (1996) (Pubitemid 26426469)
80. Powrie, F., M.W. Leach, S. Mauze, S. Menon, L.B. Caddle, & R. L. Coffman: Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity, 1, 553-562 (1994)
81. Corazza, N., S. Eichenberger, H.P. Eugster & C. Mueller: Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells. J Exp Med, 190, 1479-1491 (1999)
82. Berg, D.J., N. Davidson, R. Kuhn, W. Muller, S. Menon, G. Holland, L. Thompson-Snipes, M. W. Leach & D. Rennick: Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest, 98, 1010-1020 (1996) (Pubitemid 26293320)
83. Sandborn, W.J.: New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord, 5, 10-8 (2005) (Pubitemid 40443992)
84. Carpenter, H.A. & N. J. Talley: The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol, 95, 878-96 (2000) (Pubitemid 30196720)
85. Trinchieri, G.: Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84, 4008-4027 (1994) (Pubitemid 24371902)
86. Parronchi, P., P. Romagnani, F. Annunziato, S. Sampognaro, A. Becchio, L. Giannarini, E. Maggi, C. Pupilli, F. Tonelli & S. Romagnani: Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol, 150, 823-832 (1997)
87. Ehrhardt, R.O., B.R. Ludviksson, B. Gray, M. Neurath & W. Strober: Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol, 158, 566-573 (1997) (Pubitemid 127492631)
88. Neurath, M.F., I. Fuss, B.L. Kelsall, E. Stuber & W. Strober: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med, 182, 1281-1290 (1995)
89. Rennick, D.M. & MM Fort: Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am J Physiol-Gastro & Liver Physiol, 278, G829-833 (2000) (Pubitemid 30439159)
90. Mannon, P.J., Fuss IJ, Mayer L, Elson C.O., Sandborn WJ, Present D, Dolin B, Goodman N., Groden C, Hornung RL, Quezado M, Yang Z., Neurath MF, Salfeld J, Veldman GM, Schwertschlag U, W. Strober: Anti-IL-12 Crohn's Disease Study Group: Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med, 351, 2069-79 (2004) (Pubitemid 39482500)
91. Sandborn, W.J., B.G. Feagan, R.N. Fedorak, E. Scherl, M.R. Fleisher, S. Katz, J. Johanns, M. Blank, P. Rutgeerts & Ustekinumab Crohn's Disease Study Group: A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology, 135, 1130-41 (2008)
92. Elson, C.O., Y. Cong, C.T. Weaver, T.R. Schoeb, T.K. McClanahan, R.B. Fick & R.A. Kastelein: Monoclonal anti-interleukin 23 reverses active colitis in a T cellmediated model in mice. Gastroenterology, 132, 2359-70 (2007) (Pubitemid 46890867)
93. Alex, P., N.C. Zachos, T. Nguyen, L. Gonzales, T.E. Chen, L.S. Conklin, M. Centola & X. Li: Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis, 15, 341-52 (2009)
94. Ito, R., M. Kita, M. Shin-Ya, T. Kishida, A. Urano, R. Takada, J. Sakagami, J. Imanishi, Y. Iwakura, T. Okanoue, T. Yoshikawa, K. Kataoka & O. Mazda: Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun, 377, 12-6 (2008)
95. Ogawa, A., A. Andoh, Y. Araki, T. Bamba & Y. Fujiyama: Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol, 110, 55-62 (2004) (Pubitemid 38177420)
96. Plevy, S., B. Salzberg, G. Van Assche, M. Regueiro, D. Hommes, W. Sandborn, S. Hanauer, S. Targan, L. Mayer, U. Mahadevan, M. Frankel & J. Lowder: A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology, 133, 1414-22 (2007) (Pubitemid 350029746)
97. Tao, G.Z., P. Strnad, Q. Zhou, A. Kamal, L. Zhang, N.D. Madani, S. Kugathasan, S.R. Brant, J.H. Cho, M.B. Omary & R.H. Duerr: Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease. Clin Gastroenterol Hepatol, 5, 857-64 (2007) (Pubitemid 47039231)
98. Kamanaka, M., S.T. Kim, Y.Y. Wan, F.S. Sutterwala, M. Lara-Tejero, J.E. Galán, E. Harhaj & R.A. Flavell: Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity, 25, 941-52 (2006) (Pubitemid 44894945)
99. Perruche, S., P. Zhang, Y. Liu, P. Saas, J.A. Bluestone & W. Chen: CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med, 14, 528-35 (2008) (Pubitemid 351655213)
100. Grimm, M.C.: New and emerging therapies for inflammatory bowel diseases. J Gastroenterol Hepatol, 24 (S3), S69-74 (2009)
101. Kelsall, B.L., E. Stuber, M. Neurath & W. Strober: Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann NY Acad Sci, 795, 116-126 (1996)
102. Mombaerts, P., E. Mizoguchi., M.J. Grusby, L.H. Glimcher, A.K. Bhan & S. Tonegawa: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell, 75, 274-282 (1993)
103. Morrissey, P.J., K. Charrier, S. Braddy, D. Liggitt & J.D. Watson: CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med, 178, 237-244 (1993) (Pubitemid 23173259)
104. Matsumoto, S., Y. Okabe, H. Setoyama, K. Takayama, J. Ohtsuka, H. Funahashi, A. Imaoka, Y. Okada & Y. Umesaki: Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut, 43, 71-78 (1998) (Pubitemid 28335492)
105. Bhavsar, M.D. & M.M. Amiji: Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease. Gene Ther, 15, 1200-9 (2008)
106. Davidson, N.J.: The therapeutic potential of anti-cytokine antibodies in the treatment of chronic inflammatory disease. Expert Opin Investig Drugs, 7, 1115-20 (1998) (Pubitemid 28323095)
107. Magram, J., S.E. Connaughton, R.R. Warrier, D.M. Carvajal, C.Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D.A. Faherty & M.K. Gately: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity, 4, 471-81 (1996) (Pubitemid 26354656)
108. Boushey, R.P., B. Yusta & D.J. Drucker: Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Cancer Res, 61, 687-93 (2001) (Pubitemid 32128634)
109. Hartmann, B., J. Thulesen, H. Kissow, S. Thulesen, C. Orskov, C. Ropke, S.S. Poulsen & J.J. Holst: Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology, 141, 4013-20 (2000)
110. Yazbeck, R., G.S. Howarth, M.S. Geier, H.U. Demuth & C.A. Abbott: Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice. Front Biosci, 13, 6850-8 (2008)
111. Heazlewood, C.K., M.C. Cook, R. Eri, G.R. Price, S.B. Tauro, D. Taupin, D.J. Thornton, C.W. Png, T.L. Crockford, R.J. Cornall, R. Adams, M. Kato, K.A. Nelms, N.A. Hong, T.H. Florin, C.C. Goodnow & M.A. McGuckin: Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med, 5, e54 (2008)
112. Kang, S.S., S.M. Bloom, L.A. Norian, M.J. Geske, R.A. Flavell, T.S. Stappenbeck & P.M. Allen: An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med, 5, e41. (2008)
113. Pousa, I.D., J. Maté & J. p. Gisbert: Angiogenesis in inflammatory bowel disease. Eur J Clin Invest, 38, 73-81 (2008) (Pubitemid 351143416)
114. Thatch, K.A., K.G. Mendelson, M.M. Haber & M.Z. Schwartz: Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease. J Surg Res, 156, 245-9 (2009)
115. Barker, N., M. van de Wetering & H. Clevers: The intestinal stem cell. Genes Dev, 22, 1856-64 (2008) (Pubitemid 352008634)
116. van der Flier, L.G. & H. Clevers: Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol, 71, 241-60 (2009)
117. Wang, P. & S.X. Hou: Regulation of intestinal stem cells in mammals and Drosophila. J Cell Physiol, 222, 33-7 (2010)
118. Wright, N.A.: Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer. Int J Exp Pathol, 81, 117-143 (2000) (Pubitemid 30253351)
119. Singh, S.R. & S.X. Hou: Lessons learned about adult kidney stem cells from the malpighian tubules of Drosophila. J Am Soc Nephrol, 19, 660-6 (2008)
120. Brittan, M., M.R. Alison, S. Schier & N. A. Wright: Bone marrow stem cell-mediated regeneration in IBD: where do we go from here? Gastroenterology, 132, 1171-3 (2007) (Pubitemid 46440884)
121. Powell, D.W., R.C. Mifflin, J.D. Valentich, S.E. Crowe, J.I. Saada & A.B. West: Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol, 277, 183-201 (1999)
122. Otte, J.M., I.M. Rosenberg & D.K. Podolsky: Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology, 124, 1866-1878 (2003) (Pubitemid 36666782)
123. Saada, J.I., C.A. Barrera, V.E. Reyes, P.A. Adegboyega, Suarez G, Tamerisa RA, Pang K.F., Bland DA, R. C. Mifflin, J.F. DIM, & D.W. Powell: Intestinal myofibroblasts and immune tolerance. Ann N Y Acad Sci, 1029, 379-381 (2004) (Pubitemid 40298558)
124. Andoh, A., S. Fujino, T. Okuno, Y. Fujiyama & T. Bamba: Intestinal subepithelial myofibroblasts in inflammatory bowel diseases. Gastroenterol, 37, 33-7 (2002) (Pubitemid 35385923)
125. Gordon, J.N., K.M. Pickard, A. Di Sabatino, J.D. Prothero, S.L. Pender, P.M. Goggin & T.T. MacDonald: Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease. Inflamm Bowel Dis, 14, 195-203 (2008) (Pubitemid 351288040)
126. Beyth, S., Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun & J. Rachmilewitz: Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, 2214-9 (2005) (Pubitemid 40731815)
127. González, M. A., E. Gonzalez-Rey, L. Rico, D. Büscher & M. Delgado: Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology, 136, 978-89 (2009)
128. Uccelli, A., Moretta, L. & V. Pistoia: Mesenchymal stem cells in health and disease. Nat Rev Immunol, 8, 726-36 (2008)
129. Panés, J., & A. Salas: Mechanisms underlying the beneficial effects of stem cell therapies for inflammatory bowel diseases. Gut, 58, 898-900 (2009)
130. Lanzoni, G., F. Alviano, C. Marchionni, L. Bonsi, R. Costa, L. Foroni, G. Roda, A. Belluzzi, A. Caponi, F. Ricci, P. L. Tazzari, P. Pagliaro, R. Rizzo, F. Lanza, O. R. Baricordi, G. Pasquinelli, E. Roda, & G. p. Bagnara: Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. Cytotherapy, 11, 1020-3 (2009)
131. Schmeisser, A. & R.H. Strasser: Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J Hematother Stem Cell Res, 11, 69-79 (2002) (Pubitemid 34163771)
132. McCarroll, S.A., J.E. Bradner, H. Turpeinen, L. Volin, P.J. Martin, S.D. Chilewski, J.H. Antin, S.J. Lee, T. Ruutu, B. Storer, E.H. Warren, B. Zhang, L.P. Zhao, D. Ginsburg, R.J. Soiffer, J. Partanen, J.A. Hansen, J. Ritz, A. Palotie & D. Altshuler: Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet, 41, 1341-4 (2009)
133. Chamberlain, G., J. Fox, B. Ashton & J. Middleton: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 25, 2739-49 (2007) (Pubitemid 350127858)
134. Murry, C. E. & G. Keller: Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell, 132, 661-80 (2008) (Pubitemid 351260059)
135. Srivastava, A.S., Z. Feng, R. Mishra, R. Malhotra, H.S. Kim & E. Carrier: Embryonic stem cells ameliorate piroxicam-induced colitis in IL10-/-KO mice. Biochem Biophys Res Commun, 361, 953-9 (2007) (Pubitemid 47259028)
136. Zhang, Q., S. Shi, Y. Liu, J. Uyanne, Y. Shi, S. Shi & A. D. Le: Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol, 183, 7787-98 (2009)
137. Drakos, P.E., A. Nagler, & R. Or: Case of Crohn's disease in bone marrow transplantation. Am J Hematol, 43, 57-158 (1993)
138. Snowden, J.A., P. M. Brooks, & J.C. Biggs: Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol, 99, 9-22 (1997) (Pubitemid 27461321)
139. Lopez-Cubero, S.O., K.M. Sullivan, & G.B. McDonald: Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 114, 433-440 (1998)
140. Craig, R.M., A. Traynor, Y. Oyama, & R. K. Burt: Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplant, 32, 57-59 (2003)
141. Burt, R.K., A. Traynor, Y. Oyama & R. Craig: High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood, 101, 2064-2066 (2003) (Pubitemid 36237615)
142. Oyama, Y., R. M. Craig, A. E. Traynor, K. Quigley, L. Statkute, A. Halverson, M. Brush, Verda L., B. Kowalska, N. Krosnjar, M. Kletzel, P. F. Whitington & R. K. Burt: Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology, 128, 552-563 (2005) (Pubitemid 40585356)
143. Garcia-Olmo, D., M. Garcia-Arranz, D. Herreros, I. Pascual, C. Peiro & J.A. Rodriguez-Montes: A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum, 48, 1416-1423 (2005) (Pubitemid 40933870)
144. Wei, Y., Y. Nie, J. Lai, Y.J. Wan, & Y. Li: Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model. Transplantation, 88, 42-8 (2009)
145. Sandborn, W.J. & S.R. Targarn: Biologic therapy of inflammatory bowel disease. Gastroenterol, 122, 1592-1608 (2002). (Pubitemid 34533555)